IKS Health acquires TruBridge (TBRG) for $26.25 cash per share and delists stock
Rhea-AI Filing Summary
TruBridge, Inc. has been acquired and taken private by Inventurus Knowledge Solutions, Inc. (IKS Health). On July 9, 2026, Merger Sub was merged into TruBridge, which now operates as a wholly owned subsidiary of the buyer.
At the merger effective time, each share of TruBridge common stock (other than excluded and appraisal shares) was converted into the right to receive $26.25 per share in cash, without interest. In connection with closing, TruBridge repaid in full and terminated its existing Amended and Restated Credit Agreement, including all related guarantees and liens.
The acquirer funded the deal through $635.0 million of senior secured credit facilities. TruBridge requested Nasdaq delist its common stock, which ceased trading before the July 9, 2026 market open, and the company plans to deregister the shares and suspend its SEC reporting obligations following effectiveness of a Form 25 and subsequent Form 15 filing.
Positive
- None.
Negative
- None.
Insights
TruBridge is being taken private for cash, with debt-funded backing and delisting.
The transaction converts each TruBridge common share into $26.25 in cash and makes the company a wholly owned subsidiary of Inventurus Knowledge Solutions, Inc.. This is a full change of control, shifting TruBridge from a standalone public company to part of a larger healthcare technology platform.
The buyer financed the deal with $635.0 million in senior secured credit facilities under a new Facilities Agreement. At closing, TruBridge repaid and terminated its prior Credit Agreement, including guarantees and liens, effectively refinancing its capital structure under the new ownership.
For former public shareholders, the key effect is cashing out at the per-share merger price while losing ongoing participation in TruBridge’s future performance. Operationally, TruBridge continues as a subsidiary, while its stock is delisted from Nasdaq and the company plans to deregister and suspend Exchange Act reporting after the Form 25 and Form 15 processes.
8-K Event Classification
Key Figures
Key Terms
Agreement and Plan of Merger regulatory
senior secured credit facilities financial
Form 25 regulatory
Form 15 regulatory
total addressable market financial
FAQ
What happened to TruBridge (TBRG) in the July 2026 transaction?
How was the TruBridge (TBRG) acquisition financed by the buyer?
What happens to TruBridge’s Nasdaq listing and SEC reporting after the merger?
What changes occurred to TruBridge’s debt and credit agreements at closing?
How did the TruBridge (TBRG) merger affect its directors and officers?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
||
| (Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Introductory Note
On July 9, 2026 (the “Closing Date”), Inventurus Knowledge Solutions, Inc., a Delaware corporation (“Parent”), completed the previously announced acquisition of TruBridge, Inc., a Delaware corporation (the “Company”), pursuant to the Agreement and Plan of Merger, dated as of April 23, 2026 (the “Merger Agreement”), by and among the Company, Parent, IKS Next Horizon, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and, solely for certain limited purposes as specified therein, Inventurus Knowledge Solutions Limited, an Indian public limited company (“TopCo”). Pursuant to the terms of the Merger Agreement, on the Closing Date, Merger Sub merged with and into the Company (the “Merger”), with the Company surviving as a wholly owned subsidiary of Parent (the “Surviving Corporation”).
Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of common stock, par value $0.001 per share, of the Company (the “Company Common Stock”) issued and outstanding immediately prior to the Effective Time (other than (i) shares of Company Common Stock owned by Parent, Merger Sub, the Company or any of their respective wholly-owned subsidiaries, other than shares held in a fiduciary, representative or other capacity on behalf of third parties (whether or not held in a separate account), and (ii) shares of Company Common Stock owned by stockholders of the Company who have properly demanded and not withdrawn or otherwise waived or lost such right to appraisal under Delaware law (collectively, “Excluded Shares”)) was converted into the right to receive $26.25 per share in cash, without interest (the “Per Share Merger Consideration”).
The foregoing summary does not purport to be a complete description and is qualified in its entirety by reference to the full text of the Merger Agreement, which is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The Merger Agreement and the transactions contemplated thereby, including the Merger, were previously described in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) by the Company on April 23, 2026 and the definitive proxy statement filed with the SEC by the Company on June 4, 2026 (the “Proxy Statement”).
Item 1.02 Termination of a Material Definitive Agreement.
In connection with the consummation of the Merger, on the Closing Date, the Company paid off all outstanding indebtedness and other amounts required to be paid at payoff in respect of obligations owing, and terminated the commitments, under that certain Amended and Restated Credit Agreement, dated as of November 25, 2025, by and among the Company and certain of its subsidiaries, as guarantors, certain lenders named therein, and Regions Bank, as administrative agent and collateral agent (the “Credit Agreement”). In connection with the termination of the Credit Agreement, on the Closing Date, all outstanding obligations for principal, interest and fees and other amounts required to be paid at payoff under the Credit Agreement were paid off in full and all guarantees and liens securing obligations under the Credit Agreement were terminated and released.
Item 2.01 Completion of Acquisition or Disposition of Assets.
The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference.
Pursuant to the Merger Agreement, at the Effective Time, equity-based awards outstanding under the Company’s Amended and Restated 2019 Incentive Plan and Second Amended and Restated 2019 Incentive Plan immediately prior to the Effective Time were subject to the following treatment:
| • | any vesting conditions applicable to each outstanding restricted stock award (each, a “Company RSA”) automatically accelerated in full, and such Company RSA was converted into the right to receive, with respect to each share of Company Common Stock subject to such Company RSA (subject to any proration as set forth in an applicable award agreement), the Per Share Merger Consideration (less applicable taxes required to be withheld) and cancelled pursuant to the Merger Agreement; and |
| • | any performance conditions applicable to each outstanding performance share award (each, a ”Company PSA”) automatically ceased to apply, and such Company PSA was converted into the right to receive, with |
| respect to each share of Company Common Stock subject to such Company PSA (subject to any proration as set forth in an applicable award agreement), the Per Share Merger Consideration (less applicable taxes required to be withheld) and cancelled pursuant to the Merger Agreement, provided that the number of shares of Company Common Stock subject to each such Company PSA immediately prior to the Effective Time was determined based on actual performance through the Effective Time (or, if actual performance was not reasonably determinable, target performance). |
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
The information set forth in the Introductory Note and Items 2.01 and 3.03 of this Current Report on Form 8-K is incorporated herein by reference.
In connection with the consummation of the Merger, the Company notified the Nasdaq Global Select Market (“NASDAQ”) that, at the Effective Time, each outstanding share of Company Common Stock (other than Excluded Shares) was converted into the right to receive the Per Share Merger Consideration and requested that NASDAQ withdraw the listing of the Company Common Stock. The Company requested that NASDAQ file a notification of removal from listing and/or registration on Form 25 with the SEC with respect to the delisting of the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company Common Stock ceased trading prior to the opening of the market on July 9, 2026 and will no longer be listed on NASDAQ.
In addition, upon effectiveness of the Form 25, the Company intends to file with the SEC a Form 15 terminating the registration of the Company Common Stock under Section 12(g) of the Exchange Act and suspending the reporting obligations of the Company under Sections 13(a) and 15(d) of the Exchange Act.
Item 3.03 Material Modification to Rights of Security Holders.
The information set forth in the Introductory Note and Items 2.01, 3.01, 5.01 and 5.03 of this Current Report on Form 8-K is incorporated herein by reference.
As a result of the Merger, each share of Company Common Stock that was issued and outstanding immediately prior to the Effective Time (except as described in the Introductory Note of this Current Report on Form 8-K) was cancelled and converted automatically, at the Effective Time, into the right to receive the Per Share Merger Consideration. Accordingly, at the Effective Time, the holders of such shares of Company Common Stock ceased to have any rights as stockholders of the Company, other than the right to receive the Per Share Merger Consideration.
Item 5.01 Changes in Control of Registrant.
The information set forth in the Introductory Note and Items 2.01, 3.01 and 5.03 of this Current Report is incorporated herein by reference.
As a result of the consummation of the transactions contemplated by the Merger Agreement, including the Merger, the Company became a wholly owned subsidiary of Parent at the Effective Time.
Parent funded the acquisition through debt financing pursuant to senior secured credit facilities in an aggregate principal amount of $635.0 million under a facilities agreement (the “Facilities Agreement”) dated July 3, 2026, among Inventurus Knowledge Solutions, Inc., as borrower, Inventurus Knowledge Solutions Limited, as parent, the guarantors party thereto, Citigroup Global Markets Asia Limited, Deutsche Bank AG Singapore Branch and JPMorgan Chase Bank, N.A., Hong Kong Branch, as mandated lead arrangers, underwriters and bookrunners, Export-Import Bank of India, London Branch, as mandated lead arranger, the lenders party thereto and Axis Trustee Services Ltd. Gift City Branch, as agent and security agent. Pursuant to the Facilities Agreement, the Company is required to accede to the Facilities Agreement as an additional guarantor within thirty (30) days after the date on which the first utilization of a term facility occurs.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of the Effective Time, in accordance with the terms of the Merger Agreement, (i) all of the directors of the Company immediately prior to the Effective Time ceased serving in such capacities with the Surviving Corporation and (ii) the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
Effective as of the Effective Time, in accordance with the terms of the Merger Agreement, all of the incumbent officers of the Company immediately prior to the Effective Time continued serving as officers of the Surviving Corporation. Each such officer will continue serving until such officer’s successor has been duly elected or appointed and qualified or until such officer’s earlier death, resignation or removal.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.
Pursuant to the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation was amended and restated in its entirety and, as so amended and restated, became the certificate of incorporation of the Surviving Corporation, and the bylaws of Merger Sub in effect immediately prior to the Effective Time became the bylaws of the Surviving Corporation, except that references to Merger Sub’s name were replaced with references to the Surviving Corporation’s name.
Copies of the amended and restated certificate of incorporation and the bylaws of the Surviving Corporation are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On July 9, 2026, the Company and TopCo issued a press release announcing the closing of the Merger. The press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.
The information contained under this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 hereto) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as may be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
Description of Exhibit | |
| 2.1 | Agreement and Plan of Merger, dated April 23, 2026, by and among TruBridge, Inc., Inventurus Knowledge Solutions, Inc., IKS Next Horizon, Inc. and, for certain limited purposes, Inventurus Knowledge Solutions Limited (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on April 23, 2026). | |
| 3.1 | Amended and Restated Certificate of Incorporation of TruBridge, Inc. | |
| 3.2 | Amended and Restated Bylaws of TruBridge, Inc. | |
| 99.1 | Press Release, dated July 9, 2026, by TruBridge, Inc. and Inventurus Knowledge Solutions Limited. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| TRUBRIDGE, INC. | ||||||
| Date: July 9, 2026 | By: | /s/ Christopher L. Fowler | ||||
| Name: Christopher L. Fowler | ||||||
| Title: President and Chief Executive Officer | ||||||
Exhibit 99.1
|
|
IKS Health Completes Acquisition of TruBridge
Combined organization poised to become the technology backbone of rural and community care
DALLAS, TX / MOBILE, AL – July 9, 2026 – IKS Health, a global leader in care enablement solutions across the patient journey, today announced the successful completion of its previously announced acquisition of TruBridge™, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.
With nearly one in five Americans facing challenges accessing care, rural and community hospitals are under immediate pressure to alleviate administrative, clinical, and operational burdens. To address these systemic challenges, IKS Health is developing a purpose-built, intelligent healthcare operating system designed to optimize the entire care journey.
“Through this market expansion, we are uniting capabilities that move us further toward our goal of a combined system of record and system of action workflow that uses explainable AI-driven and human-in-the loop solutions to reduce administrative friction, ease financial pressures, and close critical gaps in patient care,” said Sachin K. Gupta, Founder and Global CEO of IKS Health. “With TruBridge as part of our organization, we can now extend a range of offerings to healthcare organizations, from independent practices and rural community hospitals to large health systems.”
The combined organization supports more than 2,000 healthcare organizations and over 150,000 clinicians across the U.S. Customers of all sizes can expect continued, uninterrupted support, and expanded investment in future innovation. Existing products will remain available as standalone offerings to ensure complete continuity of service. By driving financially sustainable, high-quality, and accountable care across the acute and ambulatory continuum, this scalable technology will deliver transformative value across the entire combined client base, regardless of EHR infrastructure.
|
|
|
This acquisition represents a pivotal investment in the rural and community health sector, positioning IKS Health to capture a significant share of a $260 billion total addressable market. By accelerating the deployment of advanced AI capabilities, including specialized large language model (LLM) solutions, IKS Health will enable customers to automate complex workflows and unlock greater value from their clinical data. The transaction is structured to drive long-term shareholder value by broadening customer reach, deepening cross-sell opportunities, and creating a highly scalable business primed for sustainable, profitable growth.
Building on IKS Health’s 20-year award-winning history of revenue cycle excellence, dedicated stewardship, financial strength, and client retention, combined with TruBridge’s trusted EHR platform, award-winning revenue cycle technology, advanced medical coding capabilities, and deep experience across hospital and community-based care, the combined entity is uniquely positioned to deliver multi-layered value across the healthcare ecosystem:
| • | For patients and communities: Fewer gaps in care, enhanced digital experiences, and healthcare that is easier to access and sustain locally. |
| • | For clinicians and care teams: Drastically reduced administrative burdens, letting clinicians practice medicine with focus, purpose, and presence. |
| • | For healthcare organizations: Stronger financial performance, more reliable operations, and the financial stability required to sustain their clinical mission. |
“We are pleased to partner with IKS Health, as we share a deep, long-term commitment to helping healthcare organizations run efficiently, strengthen their financial health, and empower clinicians to practice at the top of their license,” said Chris Fowler, CEO of TruBridge. “By uniting our capabilities, we are helping healthcare organizations optimize their performance, build operational strength, and seamlessly navigate the complexities of the modern patient journey.”
About IKS Health
IKS Health reduces the administrative, clinical, and operational burdens that slow healthcare down, giving clinicians and care teams the freedom to focus on delivering exceptional care. Through its Care Enablement platform, IKS Health integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better outcomes, and financially sustainable growth across the care journey. Founded in 2006 and recognized by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with a DORA Award for “Augmenting Human Expertise with AI,” IKS Health partners with the largest health systems, physician groups, and specialty practices across the United States. Learn more at ikshealth.com.
|
|
|
Inventurus Knowledge Solutions Limited is listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE). {Scrip codes: NSE - IKS and BSE - 544309}
About TruBridge
TruBridge proudly supports rural and community healthcare providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, TruBridge offers a mix of technology, services, and strategic expertise — including revenue cycle management (RCM), electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, deeply personal care close to home. Learn more at trubridge.com.
MEDIA CONTACT - IKS HEALTH (US)
Jill Gross, Director of Public Relations and Communications
press@ikshealth.com
MEDIA CONTACT - IKS HEALTH (India)
Sameer Arora, SVP | press@ikshealth.com
INVESTOR RELATIONS - IKS HEALTH (India)
Saransh Mundra, VP | investor_relations@ikshealth.com
MEDIA CONTACT - TRUBRIDGE
Jamie Gier, SVP of Corporate Marketing
media@trubridge.com
INVESTOR RELATIONS CONTACT - TRUBRIDGE
Asher Dewhurst, ICR Healthcare
TBRGIR@icrhealthcare.com